Developing Microphysiological Systems for Use as Regulatory Tools- Challenges and Opportunities Workshop May 10, 2013
Final agenda now available (PDF)
The Food and Drug Administration (FDA), National Institutes of Health, National Institute for Environmental Health Sciences (NIEHS) and National Center for Advancing Translational Science (NCATS), Environmental Protection Agency (EPA), Johns Hopkins School of Public Health Center for Alternatives to Animal Testing (CAAT) and the International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) are collaborating to present a workshop titled Developing Microphysiological Systems for Use as Regulatory Tools- Challenges and Opportunities on May 10, 2013.
Scientists are developing microsystems using human cells to test the effects of drugs or other substances, and these systems would improve toxicity testing beyond currently available tools. This innovation in toxicology testing is important to the development of medical products so that toxicity may be identified earlier in product development, lower costs and speed new treatments to patients.
The workshop’s goal is to provide a forum for in academia, industry and regulatory agencies to address two objectives: 1) discuss essential elements needed to develop microphysiological systems as regulatory tools and 2) discuss pathways to qualification as regulatory tools.
See link for more information.